Evidence map›Paper›PMID 31821333›Full record

Observational studyPloS one2019

Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population.

Iker Alegria-Lertxundi, Carmelo Aguirre, Luis Bujanda, Francisco Javier Fernández, Francisco Polo, José M Ordovás, M Carmen Etxezarraga, Iñaki Zabalza, Mikel Larzabal, Isabel Portillo and 4 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 2 countries.

Iker Alegria-LertxundiDepartment of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.
Carmelo AguirreBIOMICs Research Group, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.
Luis BujandaDepartment of Gastroenterology, Donostia University Hospital / BioDonostia Institute, Biomedicine Research Networking Center - CIBER of Hepatic and Digestive Diseases (CIBERehd), University of the Basque Country, UPV/EHU, San Sebastian, Spain.ORCID 0000-0002-4353-9968
Francisco Javier FernándezDepartment of Gastroenterology, Galdakao-Usansolo Hospital, Osakidetza, Galdakao, Spain.
Francisco PoloDepartment of Gastroenterology, Basurto University Hospital, Osakidetza, Bilbao, Spain.
José M OrdovásNutrition and Genomics Laboratory, Jean Mayer Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts, United States of America.
M Carmen EtxezarragaDepartment of Pathology, Basurto Hospital, Osakidetza, Bilbao, Spain.
Iñaki ZabalzaDepartment of Pathology, Galdakao-Usansolo Hospital, Osakidetza, Galdakao, Spain.
Mikel LarzabalDepartment of Pathology, Donostia University Hospital / BioDonostia Institute, Biomedicine Research Networking Center - CIBER of Hepatic and Digestive Diseases (CIBERehd), San Sebastian, Spain.
Isabel PortilloColorectal Cancer Screening Programme, The Basque Health Service, Bilbao, Spain.
Marian M de PancorboBIOMICs Research Group, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.
Leire Palencia-MadridBIOMICs Research Group, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.
Ana M RocandioDepartment of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.
Marta Arroyo-IzagaDepartment of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country, UPV/EHU, Vitoria-Gasteiz, Spain.ORCID 0000-0001-5592-4241
University of the Basque Country · ESHospital de Galdakao · ESBasque Government · ESBiogipuzkoa Health Research Institute · ESHospital de Basurto · ESMadrid Institute for Advanced Studies · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Given the significant population diversity in genetic variation, we aimed to investigate whether single nucleotide polymorphisms (SNPs) previously identified in studies of colorectal cancer (CRC) susceptibility were also relevant to the population of the Basque Country (North of Spain). We genotyped 230 CRC cases and 230 healthy controls for 48 previously reported CRC-susceptibility SNPs. Only the rs6687758 in DUPS10 exhibited a statistically significant association with CRC risk based on the crude analysis. The rs6687758 AG genotype conferred about 2.13-fold increased risk for CRC compared to the AA genotype. Moreover, we found significant associations in cases between smoking status, physical activity, and the rs6687758 SNP. The results of a Genetic Risk Score (GRS) showed that the risk alleles were more frequent in cases than controls and the score was associated with CRC in crude analysis. In conclusion, we have confirmed a CRC susceptibility locus and the existence of associations between modifiable factors and the rs6687758 SNP; moreover, the GRS was associated with CRC. However, further experimental validations are needed to establish the role of this SNP, the function of the gene identified, as well as the contribution of the interaction between environmental factors and this locusto the risk of CRC.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseCase-Control StudiesColorectal NeoplasmsFemaleHumansMaleMiddle AgedPolymorphism, Single NucleotideRisk FactorsSpain

Identifiers

PMID31821333
PMCPMC6903717
OpenAlexW2995936595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.